SEARCH BY
Alcon, Inc. is an eye care company that researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contacts lens solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon is located in Fort Worth, Texas and was formed in 1945.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 13 |
| Sector: Life Science M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 9 of 11 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 9 of 11 |
| Year: 2022 M&A | 2 of 2 |
| Size (of disclosed) | 2 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-23 |
Kala Pharmaceuticals - EYSUVIS & INVELTYS
Watertown, Massachusetts, United States Kala Pharmaceuticals' EYSUVIS & INVELTYS provides loteprednol etabonate suspension) 0.25% pharmaceutical eye drops and loteprednol etabonate suspension) 1%, the only corticosteroid for twice-a-day treatment of post-operative inflammation and pain following ocular surgery. |
Buy | $60M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-03-24 |
LENSAR
Orlando, Florida, United States LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR was formed in 2004 and is headquartered in Orlando, Florida. |
Buy | $430M |
